Paste your practice website. Get a live compliance score in seconds.
Enter your info below. Your full report, including exactly which pages and claims are driving your score, goes to your email.
Your site is scanned against six categories FDA and FTC have cited in real enforcement actions against regenerative medicine practices, plus Florida's required disclosure language.
FDA and FTC enforcement against stem cell and exosome marketing has increased steadily. A warning letter does not start with a lawsuit. It starts with marketing language someone flagged. Most practices never see the letter coming, because the language that triggers it usually reads as ordinary marketing copy, not as a claim.